Search Results 111-120 of 17258 for Irinotecan
Patients who previously received irinotecan. Rapid deterioration during screening prior to randomization, e.g. significant change in performance status ...
He also contributed to the pivotal study that led to regulatory approval of liposomal irinotecan for pancreatic cancer and fruquintinib for refractory ...
fluoropyrimidines (e.g., 5-fluorouracil or capecitabine), oxaliplatin, irinotecan, an anti-VEGF mAb (bevacizumab, ramucirumab, or ziv-aflibercept), and an ...
The treating investigator must deem the patient a candidate for all potential agents used in this trial (5FU, LV, oxaliplatin and irinotecan). The interval ...
Irinotecan; Iron; Lapatinib; Letermovir; Lovastatin; Magaldrate; Magnesium Carbonate; Magnesium Hydroxide; Magnesium Oxide; Magnesium Peroxide; Magnesium ...
Irinotecan (Camptosar); Olanzapine (Zyprexa); Ropinirole (Requip); Tacrine (Cognex); Theophylline (Theo Dur, etc.) Participating Mayo Clinic locations. Study ...
oxaliplatin, irinotecan, and/or bevacizumab. Participants should have received no more than 3 systemic regimens in the metastatic setting. - sqNSCLC (closed ...
The purpose of this study is to investigate the antitumor activity of navicixizumab monotherapy or in combination with paclitaxel or irinotecan in patients with ...
Drugs used in chemotherapy, such as temozolomide and irinotecan hydrochloride, work in different ways to stop the growth of tumor cells, either by killing the ...
... irinotecan), OR; Have unresectable, locally advanced or refractory TGCT (including metastatic disease). Patients in Part 2c must have measurable disease by ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.